Clinical trials
Active, not recruiting Phase 3 trials in Georgia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 9 |
| 2022 | 5 |
| 2023 | 8 |
| 2024 | 16 |
| 2025 | 11 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 59 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 4 |
| argenx | 4 |
| Hoffmann-La Roche | 3 |
| Regeneron Pharmaceuticals | 3 |
| Exelixis | 2 |
| Ipsen | 2 |
| MoonLake Immunotherapeutics AG | 2 |
| Novartis Pharmaceuticals | 2 |
| TG Therapeutics, Inc. | 2 |
| UroGen Pharma Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myasthenia Gravis | 5 |
| Arthritis, Psoriatic | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Colitis, Ulcerative | 3 |
| Melanoma | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Transitional Cell | 2 |
| Hepatitis D | 2 |
| Inflammatory Bowel Diseases | 2 |
| Multiple Sclerosis, Chronic Progressive | 2 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.